A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 6, 2008, Pages 495-501

  Thalheimer, Ulrich ^a,b   Triantos, Christos K ^a   Samonakis, Dimitrios N ^a   Zambruni, Andrea ^a   Senzolo, Marco ^a   Leandro, Gioacchino ^a   Patch, David ^a   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Anticoagulants; Liver disease; Thromboelastography

Indexed keywords

ENOXAPARIN; KAOLIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT; CITRATE SODIUM; CITRIC ACID;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; AGED; ARTIFACT; BILIARY CIRRHOSIS; BLOOD SAMPLING; COMPARATIVE STUDY; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; LIVER DISEASE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY; VIRUS HEPATITIS;

ADULT; AGED; ANTICOAGULANTS; ARTIFACTS; BLOOD SPECIMEN COLLECTION; CHOLANGITIS, SCLEROSING; CITRATES; ENOXAPARIN; FALSE POSITIVE REACTIONS; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERNATIONAL NORMALIZED RATIO; KAOLIN; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; MALE; MIDDLE AGED; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBELASTOGRAPHY; WARFARIN;

EID: 58149107965     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f9adf9     Document Type: Article

References (29)

1. Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 2001; 12:555-561.
2. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69:307-313.
3. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth 1997; 78:175-179.
4. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985; 64:888-896.
5. McNicol PL, Liu G, Harley ID, McCall PR, PrzybylowskiGM, BowkettJ,et al. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thrombelastography. Anaesth Intensive Care 1994; 22:659-665.
6. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575-578.
7. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319.
8. von Kier S, Smith A. Hemostatic product transfusions and adverse outcomes: focus on point-of-care testing to reduce transfusion need. J Cardiothorac Vasc Anesth 2000; 14:15-21.
9. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997; 42:716-720.
10. Sharma SK, Vera RL, Stegall WC, Whitten CW. Management of a postpartum coagulopathy using thrombelastography. J Clin Anesth 1997; 9:243-247.
11. Whitta RK, Cox DJ, Mallett SV. Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 1995; 74:464-468.
12. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353:139-142.
13. Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37:463-470.
14. Papatheodoridis GV, Patch D, Webster GJ, Brooker J, Barnes E, Burroughs AK. Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology 1999; 29:1085-1090.
15. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005; 54:556-563.
16. Thalheimer U, Triantos C, Samonakis D, Patch D, Burroughs AK, Riddell A, Perry D. Endogenous heparinoids in acute variceal bleeding. Gut 2005; 54:310-311.
17. Zambruni A, Thalheimer U, Coppell J, Riddell A, Mancuso A, Leandro G, et al. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and noncirrhotic patients. Scand J Gastroenterol 2004; 39:830-836.
18. Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg 2000; 90:1086-1088.
19. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004; 15:103-107.
20. Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D, Pasch T, Spahn DR. Citrate storage affects thrombelastograph analysis. Anesthesiology 2000; 92:1242-1249.
21. Mancuso A, Fung K, Cox D, Mela M, Patch D, Burroughs AK. Assessment of blood coagulation in severe liver disease using thromboelastography: use of citrate storage versus native blood. Blood Coagul Fibrinolysis 2003; 14:211-216.
22. Pivalizza EG, Waters RD. Kaolin vs. celite activated thromboelastography in patients receiving aprotinin [Abstract]. Anesth Analg 2001; 92 (Suppl):SCA56.
23. Avidan MS, Da FonsecaJ, Parmar K,Alcock E, Ponte J, Hunt BJ. The effects of aprotinin on thromboelastography with three different activators. Anesthesiology 2001; 95:1169-1174.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
25. Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002; 22:83-96.
26. Ben Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J, Burroughs A. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997; 26:554-559.
27. Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell'Era A, Fabris F, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006; 44:440-445.
28. Ng KF. Changes in thrombelastograph variables associated with aging. Anesth Analg 2004; 99:449-454.
29. Pihusch R, Rank A, Gohring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002; 37:548-555.